Price fixing
-
FCA week in review November 27 – December 1 2023
This week’s roundup includes tackling greenwashing, advice on setting aside capital to cover costs, and news of more ‘carelessness and incompetence’ over BSPS advice.
-
Major generic drug firms pay big fine, divest key lines in agreement with DOJ
DOJ resolves criminal antitrust charges against big pharma, with a novel twist as businesses agree to divest key product lines.